|
Adicet Bio Inc (NASDAQ: ACET) |
|
Adicet Bio Inc
ACET's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Adicet Bio Inc's sales fell
in IV. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.88 %
Adicet Bio Inc net loss decreased from $-29 millions, to $-29 millions in IV. Quarter 2024,
• More on ACET's Growth
|
|
Adicet Bio Inc realized a net loss in trailing twelve months.
Adicet Bio Inc realized cash reduction of $ -1.14 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.34.
• More on ACET's Valuation
|
|
|
|
|
Adicet Bio Inc realized net loss in trailing twelve months.
Adicet Bio Inc realized cash outflow of $ -1.14per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.34.
Adicet Bio Inc Price to Book Ratio is at 0.37 lower than Industry Avg. of 91.08. and higher than S&P 500 Avg. of 0.01
• More on ACET's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com